» Articles » PMID: 31199857

The Long Term Microbiota and Metabolic Status in Patients with Colorectal Cancer After Curative Colon Surgery

Overview
Journal PLoS One
Date 2019 Jun 15
PMID 31199857
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Whether there are subsequent changes of metabolic profiles and microbiota status after partial colectomy remains unknown. We evaluated and compared long-term effects of microbiota status and metabolic profiles in early colorectal cancer (CRC) patients after curative colectomy to the controls. In this cross-sectional study, we analyzed metabolic syndrome occurrence in 165 patients after curative partial colectomy with right hemicolectomy (RH) or low anterior resection (LAR) and 333 age-sex matched controls. Fecal samples from some of those with RH, LAR, and controls were analyzed by next-generation sequencing method. The occurrences of metabolic syndrome were significantly higher in patients after RH, but not LAR, when compared with the controls over the long term (> 5 years) follow-up (P = 0.020). Compared with control group, RH group showed lower bacterial diversity (P = 0.007), whereas LAR group showed significantly higher bacterial diversity at the genera level (P = 0.016). Compared with the control group, the principal component analysis revealed significant differences in bacterial genera abundance after RH and LAR (P < 0.001). Furthermore, the Firmicutes to Bacteroidetes ratio was significantly lower in the RH group than the control group (22.0% versus 49.4%, P < 0.05). In conclusion, early CRC patients after RH but not LAR were associated with a higher occurrence of metabolic syndrome than the controls during long-term follow-up. In parallel with metabolic change, patients with RH showed dysbiosis with a tendency to decreased richness and a significant decrease in the diversity of gut microbiota.

Citing Articles

Prognosis in stage II colon cancer: Expanding the horizons of risk factors.

Novoa Diaz M, Gentili C, Martin M, Carriere P World J Gastrointest Oncol. 2025; 17(2):100552.

PMID: 39958547 PMC: 11756003. DOI: 10.4251/wjgo.v17.i2.100552.


Correlations between primary tumour location, biomarkers of inflammation and lung injury, and postoperative pulmonary complications in patients underwent laparoscopic colorectomy: a propensity score matched analysis of 300 patients.

Li H, Che L, Li Y, Wang T, Min F, Xu L Front Immunol. 2025; 16:1546167.

PMID: 39949769 PMC: 11821553. DOI: 10.3389/fimmu.2025.1546167.


Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of .

Koliarakis I, Lagkouvardos I, Vogiatzoglou K, Tsamandouras I, Intze E, Messaritakis I Int J Mol Sci. 2024; 25(16).

PMID: 39201711 PMC: 11354820. DOI: 10.3390/ijms25169025.


The impact of surgery and oncological treatment on risk of type 2 diabetes onset in patients with colorectal cancer: nationwide cohort study in Denmark.

Krag C, Svane M, Madsbad S, Graversen S, Christensen J, Sorensen T Elife. 2024; 12.

PMID: 38829205 PMC: 11147501. DOI: 10.7554/eLife.89354.


Dysbiosis and Gastrointestinal Surgery: Current Insights and Future Research.

Gibiino G, Binda C, Cristofaro L, Sbrancia M, Coluccio C, Petraroli C Biomedicines. 2022; 10(10).

PMID: 36289792 PMC: 9599064. DOI: 10.3390/biomedicines10102532.


References
1.
Kirsten R, Nelson K, Ruschendorf U, Seger W, Scholz T, Kirsten E . Effects of aldosterone on lipid metabolism and renal oxygen consumption in the rat. Pflugers Arch. 1977; 368(3):189-94. DOI: 10.1007/BF00585195. View

2.
Kraus D, Jager J, Meier B, Fasshauer M, Klein J . Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res. 2005; 37(7):455-9. DOI: 10.1055/s-2005-870240. View

3.
Vrieze A, van Nood E, Holleman F, Salojarvi J, Kootte R, Bartelsman J . Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143(4):913-6.e7. DOI: 10.1053/j.gastro.2012.06.031. View

4.
Scheppach W, Pomare E, Elia M, Cummings J . The contribution of the large intestine to blood acetate in man. Clin Sci (Lond). 1991; 80(2):177-82. DOI: 10.1042/cs0800177. View

5.
Lin X, Luo J . Metabolic syndrome and gastrointestinal-hepatobiliary diseases. J Chin Med Assoc. 2016; 80(1):3-4. DOI: 10.1016/j.jcma.2016.09.002. View